心脏再同步化治疗在儿童心力衰竭中应用

doi:10.12372/jcp.2024.22e1661

摘要/Abstract

摘要：

心脏再同步化治疗（CRT）作为成人心力衰竭的一种重要非药物治疗手段，在儿童心力衰竭中的应用受到了越来越多的关注及应用，也已被初步证明在部分原发病导致的心力衰竭中有良好的疗效。本文回顾了近年来CRT在先天性心脏病、起搏诱导性心肌病等不同病因导致的儿童心力衰竭中的应用及其疗效、植入形式和不良反应，并对其进一步发展做出展望，以期为CRT在儿童心力衰竭中的适时应用提供参考。

关键词: 心力衰竭, 心脏再同步化治疗, 儿童

Abstract:

As an important non-drug treatment for heart failure in adults, cardiac resynchronization therapy (CRT) is gaining more and more interest and application in pediatric heart failure, and it has been preliminarily proved to be effective in heart failure due to some etiologies. This article reviews the application, efficacy, implantation forms and adverse reactions of CRT in children with heart failure caused by different causes such as congenital heart disease and pace-induced cardiomyopathy in recent years, and looks forward to the further development of CRT, in order to provide reference for timely application of CRT in children with heart failure.

Key words: heart failure, cardiac resynchronization therapy, child

陈若瑜, 吕铁伟. 心脏再同步化治疗在儿童心力衰竭中应用[J]. 临床儿科杂志, 2024, 42(4): 367-372.

CHEN Ruoyu, LYU Tiewei. Cardiac resynchronization therapy in children with heart failure[J]. Journal of Clinical Pediatrics, 2024, 42(4): 367-372.

参考文献 28

[1]	中华医学会儿科学分会心血管学组, 中国医师协会心血管内科医师分会儿童心血管专业委员会, 中华儿科杂志编辑委员会. 儿童心力衰竭诊断和治疗建议(2020年修订版)[J]. 中华儿科杂志, 2021, 59(2): 84-94.
[2]	Glikson M, Nielsen JC, Kronborg MB, et al. 2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy[J]. Eur Heart J, 2021, 42(35): 3427-3520. doi: 10.1093/eurheartj/ehab364 pmid: 34455430
[3]	Motonaga KS, Dubin AM. Cardiac resynchronization therapy for pediatric patients with heart failure and congenital heart disease: a reappraisal of results[J]. Circulation, 2014, 129(18): 1879-1891. doi: 10.1161/CIRCULATIONAHA.113.001383 pmid: 24799504
[4]	Heidenreich PA, Bozkurt B, Aguilar D, et al. 2022 AHA/ACC/HFSA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology/American Heart Association Joint Committee on clinical practice guidelines[J]. Circulation, 2022, 145(18): e876-e894. doi: 10.1161/CIR.0000000000001062 pmid: 35363500
[5]	张蕾, 田杰. 儿童心力衰竭的非药物治疗进展[J]. 中华实用儿科临床杂志, 2021, 36(13): 971-975.
[6]	Kubuš P, Rubáčková Popelová J, Kovanda J, et al. Long-term outcome of patients with congenital heart disease undergoing cardiac resynchronization therapy[J]. J Am Heart Assoc, 2021, 10(6): e018302. doi: 10.1161/JAHA.120.018302
[7]	Shaddy RE, George AT, Jaecklin T, et al. Systematic literature review on the incidence and prevalence of heart failure in children and adolescents[J]. Pediatr Cardiol, 2018, 39(3): 415-436. doi: 10.1007/s00246-017-1787-2 pmid: 29260263
[8]	Dubin AM, Janousek J, Rhee E, et al. Resynchronization therapy in pediatric and congenital heart disease patients: an international multicenter study[J]. J Am Coll Cardiol, 2005, 46(12): 2277-2283. pmid: 16360058
[9]	Chubb H, Rosenthal DN, Almond CS, et al. Impact of cardiac resynchronization therapy on heart transplant-free survival in pediatric and congenital heart disease patients[J]. Circ Arrhythm Electrophysiol, 2020, 13(4): e007925.
[10]	Somma V, Ha FJ, Palmer S, et al. Pacing-induced cardiomyopathy: a systematic review and meta-analysis of definition, prevalence, risk factors, and management[J]. Heart Rhythm, 2023, 20(2): 282-290. doi: 10.1016/j.hrthm.2022.09.019
[11]	Janoušek J, van Geldorp IE, Krupičková S, et al. Permanent cardiac pacing in children: choosing the optimal pacing site: a multicenter study[J]. Circulation, 2013, 127(5): 613-623. doi: 10.1161/CIRCULATIONAHA.112.115428 pmid: 23275383
[12]	刘甜, 梁东坡, 张智伟, 等. 儿童右心室起搏致心力衰竭后升级心脏再同步治疗五例长期随访[J]. 中华儿科杂志, 2019, 57(4): 281-285.
[13]	Tsujii N, Miyazaki A, Sakaguchi H, et al. High incidence of dilated cardiomyopathy after right ventricular inlet pacing in patients with congenital complete atrioventricular block[J]. Circ J, 2016, 80(5): 1251-1258. doi: 10.1253/circj.CJ-15-1122 pmid: 27008922
[14]	Cioffi GM, Gasperetti A, Tersalvi G, et al. Etiology and device therapy in complete atrioventricular block in pediatric and young adult population: Contemporary review and new perspectives[J]. J Cardiovasc Electrophysiol, 2021, 32(11): 3082-3094. doi: 10.1111/jce.v32.11
[15]	Rupp S, Jux C. Advances in heart failure therapy in pediatric patients with dilated cardiomyopathy[J]. Heart Fail Rev, 2018, 23(4): 555-562. doi: 10.1007/s10741-018-9692-1 pmid: 29564593
[16]	Kim DH, Choi ES, Kwon BS, et al. Development of cardiac events and functional recovery prediction models for pediatric dilated cardiomyopathy[J]. Front Pediatr, 2021, 9: 736872. doi: 10.3389/fped.2021.736872
[17]	Janousek J, Gebauer RA, Abdul-Khaliq H, et al. Cardiac resynchronisation therapy in paediatric and congenital heart disease: differential effects in various anatomical and functional substrates[J]. Heart, 2009, 95(14): 1165-1171. doi: 10.1136/hrt.2008.160465 pmid: 19307198
[18]	Sun S, Guo X, Chen Y, et al. Left ventricular epicardial pacing achieved hyper-responsiveness in young children with dilated cardiomyopathy with left bundle branch block[J]. ESC Heart Fail, 2021, 8(6): 4772-4779. doi: 10.1002/ehf2.13657 pmid: 34729942
[19]	Ergul Y, Sevinc Sengul F, Öztürk E, et al. Cardiac resynchronization therapy in paediatric patients with congenital heart disease: single centre with 10 years of experience[J]. Cardiol Young, 2021, 31(6): 940-948. doi: 10.1017/S1047951120004795 pmid: 33500007
[20]	陈轶维, 赵文婥, 王顺民, 等. 膜部室间隔缺损封堵术后完全性左束支传导阻滞治疗效果分析[J]. 临床儿科杂志, 2020, 38(2): 123-128.
[21]	Hill AC, Silka MJ, Bar-Cohen Y. Cardiac resynchronization therapy in pediatrics[J]. J Innov Card Rhythm Manag, 2018, 9(8): 3256-3264.
[22]	Mah DY, O'Leary ET, Harrild DM, et al. Resynchronizing right and left ventricles with right bundle branch block in the congenital heart disease population[J]. JACC Clin Electrophysiol, 2020, 6(14): 1762-1772. doi: 10.1016/j.jacep.2020.06.006
[23]	Cecchin F, Frangini PA, Brown DW, et al. Cardiac resynchronization therapy (and multisite pacing) in pediatrics and congenital heart disease: five years experience in a single institution[J]. J Cardiovasc Electrophysiol, 2009, 20(1): 58-65. doi: 10.1111/jce.2008.20.issue-1
[24]	Chubb H, Bulic A, Mah D, et al. Impact and modifiers of ventricular pacing in patients with single ventricle circulation[J]. J Am Coll Cardiol, 2022, 80(9): 902-914. doi: 10.1016/j.jacc.2022.05.053 pmid: 36007989
[25]	Piccini JP, Russo AM, Sharma PS, et al. Advances in cardiac electrophysiology[J]. Circ Arrhythm Electrophysiol, 2022, 15(12): e009911.
[26]	Linde C. Cardiac resynchronization in heart failure: recent advances and their practical implications[J]. Kardiol Pol, 2023, 81(1): 7-13. doi: 10.33963/KP.a2023.0020 pmid: 36744912
[27]	Linhart M, Doltra A, Acosta J, et al. Ventricular arrhythmia risk is associated with myocardial scar but not with response to cardiac resynchronization therapy[J]. Europace, 2020, 22(9): 1391-1400. doi: 10.1093/europace/euaa142 pmid: 32898254
[28]	Liang Y, Wang J, Gong X, et al. Left bundle branch pacing versus biventricular pacing for acute cardiac resynchronization in patients with heart failure[J]. Circ Arrhythm Electrophysiol, 2022, 15(11): e011181.